NO20010622L - Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists - Google Patents

Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists

Info

Publication number
NO20010622L
NO20010622L NO20010622A NO20010622A NO20010622L NO 20010622 L NO20010622 L NO 20010622L NO 20010622 A NO20010622 A NO 20010622A NO 20010622 A NO20010622 A NO 20010622A NO 20010622 L NO20010622 L NO 20010622L
Authority
NO
Norway
Prior art keywords
preparation
carboxylic acid
acid derivatives
receptor antagonists
endothelin receptor
Prior art date
Application number
NO20010622A
Other languages
Norwegian (no)
Other versions
NO20010622D0 (en
Inventor
Wilhelm Amberg
Rolf Jansen
Georg Kettschau
Stefan Hergenroeder
Manfred Raschack
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20010622D0 publication Critical patent/NO20010622D0/en
Publication of NO20010622L publication Critical patent/NO20010622L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Foreliggende oppfinnelse angår karboksylsyrederivater med formel l hvor substituentene har betydningene forklart i beskrivelsen, deres fremstilling og anvendelse derav som endotelin-reseptorantagonister.The present invention relates to carboxylic acid derivatives of formula I wherein the substituents have the meanings explained in the specification, their preparation and use thereof as endothelin receptor antagonists.

NO20010622A 1998-08-10 2001-02-06 Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists NO20010622L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19836044A DE19836044A1 (en) 1998-08-10 1998-08-10 New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer
PCT/EP1999/005728 WO2000009489A1 (en) 1998-08-10 1999-08-07 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists

Publications (2)

Publication Number Publication Date
NO20010622D0 NO20010622D0 (en) 2001-02-06
NO20010622L true NO20010622L (en) 2001-02-06

Family

ID=7876981

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010622A NO20010622L (en) 1998-08-10 2001-02-06 Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists

Country Status (22)

Country Link
EP (1) EP1104410A1 (en)
JP (1) JP2002522531A (en)
KR (1) KR20010072378A (en)
CN (1) CN1323298A (en)
AR (1) AR020147A1 (en)
AU (1) AU5374199A (en)
BG (1) BG105236A (en)
BR (1) BR9912889A (en)
CA (1) CA2340167A1 (en)
CO (1) CO5261504A1 (en)
DE (1) DE19836044A1 (en)
HK (1) HK1042086A1 (en)
HR (1) HRP20010164A2 (en)
HU (1) HUP0104007A3 (en)
ID (1) ID27965A (en)
IL (1) IL140915A0 (en)
NO (1) NO20010622L (en)
PL (1) PL345998A1 (en)
SK (1) SK832001A3 (en)
TR (1) TR200100427T2 (en)
WO (1) WO2000009489A1 (en)
ZA (1) ZA200101975B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (en) * 1999-06-01 2000-12-07 Basf Ag New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636046A1 (en) * 1996-09-05 1998-03-12 Basf Ag New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists

Also Published As

Publication number Publication date
SK832001A3 (en) 2001-11-06
BG105236A (en) 2001-12-29
BR9912889A (en) 2001-05-08
JP2002522531A (en) 2002-07-23
HUP0104007A2 (en) 2002-05-29
TR200100427T2 (en) 2001-07-23
PL345998A1 (en) 2002-01-14
CA2340167A1 (en) 2000-02-24
WO2000009489A1 (en) 2000-02-24
AR020147A1 (en) 2002-04-10
NO20010622D0 (en) 2001-02-06
DE19836044A1 (en) 2000-02-17
HUP0104007A3 (en) 2002-12-28
EP1104410A1 (en) 2001-06-06
CN1323298A (en) 2001-11-21
CO5261504A1 (en) 2003-03-31
ZA200101975B (en) 2002-03-11
ID27965A (en) 2001-05-03
KR20010072378A (en) 2001-07-31
HK1042086A1 (en) 2002-08-02
IL140915A0 (en) 2002-02-10
HRP20010164A2 (en) 2002-04-30
AU5374199A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
NO20054848L (en) Substituted p-diaminobenzene derivatives
NO991761L (en) New piperidine cotocarboxylic acid derivatives, their preparation and use
NO20064415L (en) Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
NO20063748L (en) Quinoline derivatives and their use as mycobacterial inhibitors
NO20044731L (en) Quinoline and Isoquinoline Derivatives Process for Preparation thereof and its Use as Inflammatory Inhibitors
DE60141895D1 (en) SUBSTITUTED BETA-CARBOLINE WITH IKB-KINASE HEMMENDER EFFECT
CY1107281T1 (en) TROPANI PRODUCTS Substituted with Ididazopyridine with CCR5 Antagonist Activity Receptor for HIV and Inflammation Therapy
DE69912581D1 (en) BIARYL ACETIC ACID DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS
NO20054726L (en) 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammation and immune system disorders
NO20052520D0 (en) New sulfamides
NO20070089L (en) DPP-IV inhibitors
ATE381546T1 (en) PYRIMIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
NO20061789L (en) Aminopyridine derivatives as inducible NO synthase inhibitors
NO20002124L (en) Novel Carboxylic Acid Derivatives with Amide Side Chains, Their Preparation and Use as Endothelin Receptor Antagonists
DK1513800T3 (en) Benzoylureido-cinnamic acid derivatives, process for their use
NO20012544L (en) Substituted benzo [de] isoquinoline-1,3-dione
EA200601176A1 (en) 3-CYANOHINOLINE DERIVATIVES WITH ANTIPROLIFERATIVE ACTIVITY
MXPA05009282A (en) Substituted aniline derivatives.
NO20064417L (en) Novel isoamidosubstituted hydroxy-6-phenylphenanthridines
NO20001934L (en) 3-Substituted tetrahydropyridopyrimidinone derivatives, their preparation and use
NO20010622L (en) Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists
NO20070878L (en) Dimeric piperidine derivatives
TR199901416T2 (en) Heterocyclic carbonicacyte térevleri.
TR199903159T2 (en) New �-Amino and �-Azido carbonic acid derivatives.
NO20002154L (en) Novel heterocyclic substituted alpha hydroxycarboxylic acid derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application